Related references
Note: Only part of the references are listed.Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses
John Trachtenberg et al.
BJU INTERNATIONAL (2008)
Motexafin lutetium-photodynamic therapy of prostate cancer: Short- and long-term effects on prostate-specific antigen
Hiral Patel et al.
CLINICAL CANCER RESEARCH (2008)
Focal therapy for prostate cancer
Thomas J. Polascik et al.
CURRENT OPINION IN UROLOGY (2008)
Contrast-Enhanced Ultrasound and Prostate Cancer; A Multicentre European Research Coordination Project
Margot Wink et al.
EUROPEAN UROLOGY (2008)
Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy
Jun Li et al.
PHYSICS IN MEDICINE AND BIOLOGY (2008)
Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate
Shimrit Fleshker et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
Active surveillance for prostate cancer: trials and tribulations
Laurence Klotz
WORLD JOURNAL OF UROLOGY (2008)
Evaluation of the new photosensitizer stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes
Marianne Berdugo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Acne vulgaris: lasers, light sources and photodynamic therapy - an update 2007
Michael H. Gold
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities
Scott E. Eggener et al.
JOURNAL OF UROLOGY (2007)
Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: Assessment of safety and treatment response
J. Trachtenberg et al.
JOURNAL OF UROLOGY (2007)
Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate
Ann Johansson et al.
MEDICAL PHYSICS (2007)
The current use and future trends of focal surgical therapy in the management of localized prostate cancer
Al B. Barqawi et al.
CANCER JOURNAL (2007)
Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide
Masoom A. Haider et al.
RADIOLOGY (2007)
Control of prostate cancer by transrectal HIFU in 227 patients
Laura Poissonnier et al.
EUROPEAN UROLOGY (2007)
Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light
Guoqiang Yu et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2006)
Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy
Jarod C. Finlay et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2006)
Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland
Zheng Huang et al.
LASERS IN SURGERY AND MEDICINE (2006)
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer
C. M. Moore et al.
LASERS IN SURGERY AND MEDICINE (2006)
PDT-associated host response and its role in the therapy outcome
Mladen Korbelik
LASERS IN SURGERY AND MEDICINE (2006)
A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival
C. Parker et al.
BRITISH JOURNAL OF CANCER (2006)
Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft
Hiroaki Togashi et al.
ORAL ONCOLOGY (2006)
Photodynamic therapy for urological malignancies: Past to current approaches
JH Pinthus et al.
JOURNAL OF UROLOGY (2006)
Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid
A Curnow et al.
LASERS IN SURGERY AND MEDICINE (2006)
Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer
T Uchida et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer
K Verigos et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2006)
Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm
MD Altschuler et al.
MEDICAL PHYSICS (2005)
Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer
SF Shariat et al.
PROSTATE (2005)
Development of a novel targeting system for lethal photo sensitization of antibiotic-resistant strains of Staphylococcus aureus
ML Embleton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates
MD Savellano et al.
CANCER RESEARCH (2005)
Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements
MS Thompson et al.
APPLIED OPTICS (2005)
Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy
TC Zhu et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2005)
Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy
J Jankun et al.
BJU INTERNATIONAL (2005)
Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy
RL Schneider et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
WST11, a novel water-soluble bacteriochlorophyll derivative; Cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model
O Mazor et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2005)
Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer
L Klotz
NATURE CLINICAL PRACTICE UROLOGY (2005)
Optical properties of human prostate at 732 nm measured during motexafin lutetium-mediated photodynamic therapy
TC Zhu et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2005)
Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients
RA Weersink et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2005)
PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy
K Ichikawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Targeted photodynamic therapy via receptor mediated delivery systems
WM Sharman et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Polymeric micelles to deliver photosensitizers for photodynamic therapy
CF van Nostrum
ADVANCED DRUG DELIVERY REVIEWS (2004)
Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: Targeting and incapacitating cancer cells
X Chen et al.
BIOCHEMISTRY (2004)
Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer
PJ Lou et al.
BRITISH JOURNAL OF CANCER (2004)
The male lumpectomy: Rationale for a cancer targeted approach for prostate cryoablation. A review
G Onik
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2004)
Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: Rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors
SK Bisland et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2004)
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2
RZ Renno et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Antibody-directed photodynamic therapy of methicillin resistant Staphylococcus aureus
ML Embleton et al.
MICROBIAL DRUG RESISTANCE (2004)
Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI
S Gross et al.
NATURE MEDICINE (2003)
Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
MR Hamblin et al.
BRITISH JOURNAL OF CANCER (2003)
Photodynamic therapy for prostate cancer recurrence after radiotherapy: A phase I study
TR Nathan et al.
JOURNAL OF UROLOGY (2002)
Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro
MB Vrouenraets et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Photodynamic therapy for cancer of the pancreas
SG Bown et al.
GUT (2002)
Share Paper
